Morpholine carboxamides and use thereof
US4143140A · kind A · utility
2Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1978 |
| Grant date | Mar 6, 1979 |
| Priority date | — |
| Expiry date | May 22, 1998 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D317/64
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
1-Hydroxyphenoxy-3-ureidoethylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart failure. The compounds possess cardio-selective .beta.-adrenergic stimulant activity. Representative of the compounds disclosed is 1-p-hydroxyphenoxy-3-.beta.-(morpholinocarbonamido)ethylamino-2-propanol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.